IL33 rs11169571: Understanding This Genetic Variant
The rs11169571 variant is a noncoding genetic change located near the IL33 gene, which plays a critical role in the immune system. Research suggests this variant may influence the expression of IL-33, a protein involved in inflammatory responses and atopic conditions.
What each genotype means
Typical IL-33 expression
This genotype represents the baseline state for this regulatory variant. Research suggests this configuration is associated with standard levels of IL-33 alarmin expression in epithelial barriers, which plays a role in immune signaling. As this is a common variant, this profile is observed in a large portion of the population and is not considered a diagnostic indicator of disease.
Carried by a significant portion of the population, with the C allele being common across European and Admixed American cohorts.
Altered IL-33 expression potential
Carrying one copy of the T allele may influence the regulation of IL-33 expression in your epithelial tissues. Studies have linked this variant to early-onset atopic phenotypes, though the evidence remains limited and the functional impact can vary between individuals. This association is statistical in nature and does not guarantee the development of any specific allergic or inflammatory condition.
This heterozygous genotype is frequently observed, reflecting the high minor allele frequency of approximately 0.40 in European and Admixed American populations.
Increased IL-33 expression potential
This genotype is associated with potential changes in the expression of the IL-33 alarmin, which is involved in airway inflammation and immune responses. While some research links this variant to atopic traits, the clinical significance is not fully established and remains a subject of ongoing study. You should view this as a genetic predisposition factor rather than a definitive health outcome.
This homozygous genotype is common, consistent with the high prevalence of the T allele in European and Admixed American ancestral groups.
What is rs11169571?
The rs11169571 variant is a single nucleotide polymorphism (SNP) located in a noncoding region of the human genome. In genetics, noncoding variants do not provide instructions for building proteins directly but often function as regulatory switches. This specific SNP is situated upstream of the IL33 gene, a region known to contain regulatory elements that control how much of a gene's product is made. Because it sits in a regulatory area, researchers investigate whether this variant alters the 'volume' of IL-33 production in specific tissues, such as the epithelial barriers of the lungs or skin. It is categorized as a trait-associated variant, meaning it has been identified in studies looking for genetic links to specific physical or health-related characteristics.
The Role of the IL33 Gene
The IL33 gene encodes the interleukin-33 protein, which acts as an 'alarmin' within the body. Under normal conditions, IL-33 resides in the nucleus of cells, acting as a transcriptional repressor. However, when cells are damaged or stressed, IL-33 is released into the extracellular space. Once released, it functions as a potent cytokine, signaling to immune cells to initiate an inflammatory response. This process is vital for defending the body against pathogens and repairing tissue damage. Because of its role in triggering inflammation, the regulation of IL-33 is tightly controlled. Variations in the DNA sequence near this gene, such as rs11169571, are of interest to scientists because they may disrupt this delicate balance, potentially leading to heightened immune sensitivity or chronic inflammatory states.
Research and Evidence Strength
Current evidence linking rs11169571 to specific health outcomes is considered limited. While the IL33 locus as a whole is well-documented in genome-wide association studies (GWAS) for its role in asthma and atopic diseases, the specific functional impact of rs11169571 requires further investigation. Many variants in this region exist in linkage disequilibrium, meaning they are often inherited together, making it difficult for researchers to pinpoint which specific SNP is the primary driver of a trait. Studies have shown that variants in the IL33 upstream region can influence protein expression in airway epithelial cells, but the clinical significance of rs11169571 specifically remains an area of active research. It is important to note that genetic associations are statistical correlations and do not imply a direct cause-and-effect relationship for any individual.
Population Frequency
The rs11169571 variant is relatively common across several major population groups. Data indicates a minor allele frequency (MAF) of approximately 0.40 in European and Admixed American cohorts. This high frequency suggests that the variant is a standard part of human genetic diversity rather than a rare mutation. Because it is so common, it is likely that a large portion of the population carries at least one copy of the variant allele. Understanding its prevalence helps researchers design better studies to determine if the variant contributes to population-level differences in immune responses or susceptibility to atopic conditions.
Interpreting Your Genetic Information
If you have information about your genotype for rs11169571, it is important to view it in the context of your overall health and environment. Genetic variants are only one piece of a complex puzzle that includes lifestyle, environment, and other genetic factors. You cannot use this information to diagnose a condition or predict your future health. If you are concerned about symptoms related to allergies, asthma, or immune health, please consult with a qualified healthcare professional. They can provide a comprehensive evaluation based on your medical history and clinical presentation. Never make changes to your medications or health regimen based on genetic data without first discussing it with your doctor or pharmacist.
How common is this variant?
The variant is common, with a minor allele frequency of approximately 0.40 across European and Admixed American cohorts.
Frequently asked questions
Is rs11169571 a cause of asthma?
No, rs11169571 is not a direct cause of asthma. It is a genetic variant associated with the IL33 gene, which is involved in immune regulation, but asthma is a complex condition influenced by many genes and environmental factors.
Can I use this SNP to predict my allergy risk?
No, you cannot use this SNP to predict your risk of developing allergies. Genetic associations are statistical findings across large groups and do not provide individual diagnostic predictions.
What should I do if I have the 'risk' allele?
Having a specific allele does not mean you will develop a disease. If you have concerns about your immune health or atopic symptoms, consult a healthcare provider for a professional assessment.
Where can I find more information on IL33?
You can find reliable information on the IL33 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11169571?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL33
An intronic regulatory polymorphism in IL33 that influences expression levels and predisposes carriers to allergic rhinitis and atopic sensitization.
Interleukin-33 promoter variant modulating cytokine expression and predisposition to environmental allergies.
A regulatory SNP near the IL33 locus linked to enhanced IL-33 alarmin expression and risk of allergic rhinitis, peanut allergy, and atopic dermatitis.
Variant in IL33 associated with asthma and allergic sensitization.
This variant located near the IL33 gene is associated with an increased risk of nasal polyposis, particularly in patients with eosinophilia.